Quick Answer
iSpecimen Inc. reported Revenue (ASC 606) of $9.93 million for fiscal year 2023.
iSpecimen Inc. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2023 | $9.93M | -4.6% |
| 2022 | $10.40M | -6.6% |
| 2021 | $11.14M | +36.1% |
| 2020 | $8.18M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $2.66M | -4.2% | -7.0% |
| June 30, 2024 | $2.86M | +76.2% | +25.1% |
| March 31, 2024 | $2.29M | -22.4% | -17.6% |
| September 30, 2023 | $2.78M | +7.5% | +70.9% |
| June 30, 2023 | $1.63M | -30.5% | -44.9% |
| March 31, 2023 | $2.95M | +17.1% | +14.2% |
| September 30, 2022 | $2.58M | -5.0% | +10.5% |
| June 30, 2022 | $2.34M | -19.5% | -7.1% |
- iSpecimen Inc. showed a decrease of -4.6% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2020–2023 period, iSpecimen Inc.’s revenue (asc 606) has grown by 21.3% (from $8.18 million to $9.93 million).
- The most recent figure is from iSpecimen Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on March 13, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: